RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
RXDX
Delisted
RXDX was delisted on the 15th of June, 2023.
51 hedge funds and large institutions have $573M invested in Prometheus Biosciences, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
2% less capital invested
Capital invested by funds: $585M → $573M (-$12.3M)
Holders
51
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$4.02M | |
| 2 | +$3.5M | |
| 3 | +$2.53M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$983K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$365K |
Top Sellers
| 1 | -$3.44M | |
| 2 | -$2.65M | |
| 3 | -$1.07M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$944K |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$657K |